阿尔茨海默病的氢离子磁共振波谱特征(2)
[5]Kantarci K,Weigand SD,Peterson RC,et al.Longitudinal H MRS changes in mildcognitive impairment and Alzheimer disease.neurobiol Aging,2007,28(9):1330-1339
[6]Balland CG,Greg NH,Guillozet-Bongarrts AL,et al.Cholinesterases:role in tne brain duing health and disease.Curr Alzheimer Res,2005,2:307-318
[7]张全贵,张宁男楠.氢离子磁共振波谱及对阿尔茨海默病的诊断.中外医学研究,2010,8(21):136
[8]Modrego PJ,Pina MA,Fayod N,et al.Changes in metabolite ratios sfter treatment with rivastigmine in Alzheimers disease:a nonrandomised controlled trial with magnetic resonance spectroscopy.CNS Drugs,2006,20:867-877
[9]Jessen F,Fraeber F,Freymann K,et al.Treatment monitoring and response prediction with proton MRspectroscopy in AD.Neurology,2006,67:528-536
[10]Kantarci K,Petersen RC,Boeye BF,et al.H MR spectroscopy in common dementias.Neuyology,2004,63:1393-1399
[11]Fredercick B,Satlin A,Wald LL,et al.Brain proton magnetic resonance spectroscop in Alzheimer disease:change sfter treatment with xanometin.Am J Geriatr Psychiatry,2003,10:81-88
[12]Krishnan KR,Chardles HC,Doraiswamy PM,et al.Randomized,placebo-cled trial of donepezil on neuronal makers and hippocampal volumes in Alzeimeys disease.AmJ Psychiatry,2003,160:2003-2013
[13]车伯琛.食疗协同降糖药以降低阿尔茨海默症发作风险的探索认知.中国医学创新,2010,7(3):170-171, 百拇医药
[6]Balland CG,Greg NH,Guillozet-Bongarrts AL,et al.Cholinesterases:role in tne brain duing health and disease.Curr Alzheimer Res,2005,2:307-318
[7]张全贵,张宁男楠.氢离子磁共振波谱及对阿尔茨海默病的诊断.中外医学研究,2010,8(21):136
[8]Modrego PJ,Pina MA,Fayod N,et al.Changes in metabolite ratios sfter treatment with rivastigmine in Alzheimers disease:a nonrandomised controlled trial with magnetic resonance spectroscopy.CNS Drugs,2006,20:867-877
[9]Jessen F,Fraeber F,Freymann K,et al.Treatment monitoring and response prediction with proton MRspectroscopy in AD.Neurology,2006,67:528-536
[10]Kantarci K,Petersen RC,Boeye BF,et al.H MR spectroscopy in common dementias.Neuyology,2004,63:1393-1399
[11]Fredercick B,Satlin A,Wald LL,et al.Brain proton magnetic resonance spectroscop in Alzheimer disease:change sfter treatment with xanometin.Am J Geriatr Psychiatry,2003,10:81-88
[12]Krishnan KR,Chardles HC,Doraiswamy PM,et al.Randomized,placebo-cled trial of donepezil on neuronal makers and hippocampal volumes in Alzeimeys disease.AmJ Psychiatry,2003,160:2003-2013
[13]车伯琛.食疗协同降糖药以降低阿尔茨海默症发作风险的探索认知.中国医学创新,2010,7(3):170-171, 百拇医药